Pulmatrix (PULM) Non Operating Interest Expenses (2014 - 2022)
Pulmatrix's (PULM) quarterly Non Operating Interest Expenses came in at $51000.0 in Q2 2022, up 920.0% year-over-year from $5000.0 in Q2 2021, and up 363.64% quarter-over-quarter from $11000.0 in Q1 2022.
Analysis
Pulmatrix (PULM) Non Operating Interest Expenses (2014 - 2022) Analysis & Trends
Pulmatrix has disclosed Non Operating Interest Expenses across 8 years of filings, most recently posting $51000.0 for Q2 2022.
- In Q2 2022, Non Operating Interest Expenses rose 920.0% year-over-year to $51000.0; the TTM figure through Jun 2022 stood at $89000.0 (down 37.32% YoY), while the FY2021 annual figure was $11000.0, down 95.4% from the prior year.
- Non Operating Interest Expenses came in at $51000.0 for Q2 2022 at Pulmatrix, up from $11000.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $106000.0 in Q1 2018 to a low of $5000.0 in Q2 2021.
- Average Non Operating Interest Expenses over 4 years is $48750.0, with a median of $36500.0 recorded in 2021.
- Year-over-year, Non Operating Interest Expenses plunged 53.49% in 2018 and soared 920.0% in 2022.
- Over 4 years, Non Operating Interest Expenses stood at $106000.0 in 2018, then sank by 91.51% to $9000.0 in 2020, then tumbled by 44.44% to $5000.0 in 2021, then soared by 920.0% to $51000.0 in 2022.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $51000.0 in Q2 2022, $11000.0 in Q1 2022, and $5000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 640.32 Bn | 619.56 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 445.20 Bn | 438.64 Bn | 12.70 Bn | - |
| 3 | Merck | 357.17 Bn | 350.03 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.38 Bn | 259.69 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 156.69 Bn | 145.00 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.12 Bn | 44.74 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 42.92 Bn | 42.92 Bn | - | 23.78 Mn |
| 8 | Incyte | 24.60 Bn | 20.06 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn | 2.90 Mn |
| 10 | Pulmatrix | 5.17 Mn | 5.17 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 22,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Dec 31, 2018 | 106,000.00 |
| Jun 30, 2018 | 80,000.00 |
| Mar 31, 2018 | 106,000.00 |
| Dec 31, 2017 | 131,000.00 |
| Sep 30, 2017 | 153,000.00 |
| Jun 30, 2017 | 172,000.00 |
| Mar 31, 2017 | 187,000.00 |
| Dec 31, 2016 | 208,000.00 |
| Sep 30, 2016 | 225,000.00 |
| Jun 30, 2016 | 224,000.00 |
| Mar 31, 2016 | 223,000.00 |
| Sep 30, 2015 | 731,000.00 |
| Jun 30, 2015 | 511,000.00 |
| Mar 31, 2015 | 184,000.00 |
| Sep 30, 2014 | 14.75 Mn |